Wolverine Trading
IBB icon

Wolverine Trading’s iShares Biotechnology ETF IBB Stock Holding History

Wolverine Trading’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.79M Sell
12,539
-2,553
-17% -$348K ﹤0.01% 2285
2025
Q2 		$1.91M Buy
+15,092
New +$1.85M ﹤0.01% 1739
2024
Q3 		– Sell
-7,336
Closed -$1.01M – 5047
2024
Q2 		$1.01M Buy
+7,336
New +$979K ﹤0.01% 2188
2024
Q1 		– Sell
-2,684
Closed -$365K – 4824
2023
Q4 		$365K Buy
+2,684
New +$327K ﹤0.01% 3278
2022
Q1 		– Sell
-8,690
Closed -$1.34M – 5847
2021
Q4 		$1.34M Buy
8,690
+1,789
+26% +$277K ﹤0.01% 2298
2021
Q3 		$1.11M Buy
6,901
+4,387
+175% +$738K ﹤0.01% 2851
2021
Q2 		$411K Buy
+2,514
New +$387K ﹤0.01% 3979
2021
Q1 		– Sell
-39,326
Closed -$6M – 6096
2020
Q4 		$6M Buy
39,326
+18,675
+90% +$2.67M 0.01% 951
2020
Q3 		$2.78M Buy
+20,651
New +$2.8M 0.01% 1221
2019
Q1 		– Sell
-14,334
Closed -$1.36M – 4836
2018
Q4 		$1.36M Sell
14,334
-26,163
-65% -$2.78M ﹤0.01% 1726
2018
Q3 		$4.94M Sell
40,497
-41,627
-51% -$4.9M 0.01% 978
2018
Q2 		$8.77M Hold
82,124
– – 0.02% 569
2018
Q1 		$8.77M Sell
82,124
-7,290
-8% -$808K 0.02% 569
2017
Q4 		$9.55M Buy
+89,414
New +$9.56M 0.03% 523
2017
Q3 		– Sell
-100,080
Closed -$10.4M – 4673
2017
Q2 		$10.4M Buy
+100,080
New +$9.86M 0.05% 356
2017
Q1 		– Sell
-39,003
Closed -$3.45M – 4596
2016
Q4 		$3.45M Buy
39,003
+30,846
+378% +$2.81M 0.02% 957
2016
Q3 		$777K Sell
8,157
-32,745
-80% -$3.12M ﹤0.01% 2139
2016
Q2 		$3.49M Buy
+40,902
New +$3.67M 0.02% 778

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wolverine Trading's IBB Position: Q3 2025 in Review

Wolverine Trading reduced its iShares Biotechnology ETF (IBB) stake by 17% in Q3 2025, selling an estimated $348K and leaving 12,539 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2285.

Wolverine Trading first reported a position in IBB in Q2 2016 and has held it in 18 quarters since. The position peaked at $10.4M in Q2 2017. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Wolverine Trading held 12,539 shares of iShares Biotechnology ETF worth $1.79M as of Q3 2025.
  • Wolverine Trading sold 2,553 iShares Biotechnology ETF shares in Q3 2025, an estimated $348K.
  • iShares Biotechnology ETF made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2285 holding.
  • Wolverine Trading first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 18 quarters since.
  • Wolverine Trading's iShares Biotechnology ETF position peaked at $10.4M in Q2 2017.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.